About PPA   |   Contact Us   |   Report Abuse   |   Sign In   |   Join Now
LCPA Presents New Drug Update 2014 CE
Tell a Friend About This EventTell a Friend
 

The Lancaster County Pharmacists Association will be hosting Dr. Daniel A. Hussar on November 12, 2014 at an LCPA Meeting to present his popular New Drug Update program.

11/12/2014
When: Wednesday, November 12, 2014
6:30 to 9 PM
Where: Media Heights Golf Club
402 Golf Road
Lancaster, Pennsylvania  17602
United States
Presenter: Daniel A. Hussar, BSPharm, PhD, FAPhA
Contact: Jay Rhodes

« Go to Upcoming Event List  

Title: New Drug Update 2014

The Lancaster County Pharmacists Association will be hosting Dr. Daniel A. Hussar on November 12, 2014 at an LCPA Meeting to present his popular New Drug Update program. This presentation considers the properties and uses of selected new therapeutic agents. The indications and routes of administration for these new drugs are reviewed, as are the most important precautions and practical considerations regarding their use. Where possible, the properties of the new drugs are compared with those of older drugs marketed for the same indications. A New Drug Comparison Rating (NDCR) is provided for each of the new drugs considered.

 

Schedule:
6:30 to 7:30 PM Registration/Dinner
7:30 to 8:30 PM CE Program
8:30 to 9:00 PM LCPA Meeting

 

Cost:
Free for LCPA members
$25 for non-LCPA members (Fee can be applied toward LCPA Membership)


Registration for this event has closed!


Speaker:
Daniel A. Hussar, BSPharm, PhD, FAPhA Remington Professor of Pharmacy, Philadelphia College of Pharmacy at USP

Target Audience: All Pharmacists
Learning Objectives: At the completion of this activity, the participant will be able to:
1. Identify the indications and routes of administration of the new therapeutic agents.
2. Identify the important pharmacokinetic properties and the unique characteristics of the new drugs.
3. Identify the most important adverse events and precautions of the new drugs.
4. Compare the new drugs to the older therapeutic agents to which they are most similar in activity.
5. Identify information regarding the new drugs that should be communicated to patients.
Requirements to receive credit:
Attendees must:
1. Be present for the entire program
2. Sign the sign-in sheet
3. Complete an online evaluation survey within one week, and
4. Provide PPA with their CPE Monitor ID (NABP e-Profile ID) and date of birth.

UAN: 0159-0000-14-033-L01-P Activity Type: Knowledge-based Contact Hours: 1.0 (0.10 CEUs)



The Pennsylvania Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.


Association Management Software Powered by YourMembership  ::  Legal